Filing Details
- Accession Number:
- 0001179110-19-006616
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-24 07:19:44
- Reporting Period:
- 2019-05-23
- Accepted Time:
- 2019-05-24 07:19:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1579428 | Axsome Therapeutics Inc. | AXSM | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1295913 | E Mark Saad | C/O Axsome Therapeutics, Inc 200 Broadway, 3Rd Floor New York NY 10038 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-23 | 3,500 | $22.33 | 7,002 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is an average price. These shares were purchased by the reporting person in multiple transactions at prices ranging from $22.30 to $22.35, inclusive. The reporting person undertakes to provide to Axsome Therapeutics, Inc., the staff of the Securities and Exchange Commission, and others pursuant to applicable securities laws, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (1) to this Form 4.